My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 794

    1.

    Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance.

    de Souza CJ, Eckhardt M, Gagen K, Dong M, Chen W, Laurent D, Burkey BF.

    Diabetes. 2001 Aug;50(8):1863-71.PMID: 11473050 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Effects of pioglitazone on promoting energy storage, not expenditure, in brown adipose tissue of obese fa/fa Zucker rats: comparison to CL 316,243.

    Burkey BF, Dong M, Gagen K, Eckhardt M, Dragonas N, Chen W, Grosenstein P, Argentieri G, de Souza CJ.

    Metabolism. 2000 Oct;49(10):1301-8.PMID: 11079820 [PubMed - indexed for MEDLINE]Related articles

    3.

    Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats.

    Okuno A, Tamemoto H, Tobe K, Ueki K, Mori Y, Iwamoto K, Umesono K, Akanuma Y, Fujiwara T, Horikoshi H, Yazaki Y, Kadowaki T.

    J Clin Invest. 1998 Mar 15;101(6):1354-61.PMID: 9502777 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Effects of pioglitazone versus diet and exercise on metabolic health and fat distribution in upper body obesity.

    Shadid S, Jensen MD.

    Diabetes Care. 2003 Nov;26(11):3148-52.PMID: 14578253 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats.

    Fujiwara T, Yoshioka S, Yoshioka T, Ushiyama I, Horikoshi H.

    Diabetes. 1988 Nov;37(11):1549-58.PMID: 3053303 [PubMed - indexed for MEDLINE]Related articles

    6.

    Malonyl coenzyme A and adiposity in the Dahl salt-sensitive rat: effects of pioglitazone.

    Kurowski TG, Saha AK, Cunningham BA, Holbert RI, Colca JR, Corkey BE, Ruderman NB.

    Metabolism. 1996 Apr;45(4):519-25.PMID: 8609842 [PubMed - indexed for MEDLINE]Related articles

    7.

    Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.

    Liu LF, Purushotham A, Wendel AA, Belury MA.

    Am J Physiol Gastrointest Liver Physiol. 2007 Jun;292(6):G1671-82. Epub 2007 Feb 22.PMID: 17322064 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Insulin-sensitizing effect of rosiglitazone (BRL-49653) by regulation of glucose transporters in muscle and fat of Zucker rats.

    Kramer D, Shapiro R, Adler A, Bush E, Rondinone CM.

    Metabolism. 2001 Nov;50(11):1294-300.PMID: 11699047 [PubMed - indexed for MEDLINE]Related articles

    9.

    Pioglitazone-induced increase of insulin sensitivity in the muscles of the obese Zucker fa/fa rat cannot be explained by local adipocyte differentiation.

    Hallakou S, Foufelle F, Doaré L, Kergoat M, Ferré P.

    Diabetologia. 1998 Aug;41(8):963-8.PMID: 9726600 [PubMed - indexed for MEDLINE]Related articles

    10.

    Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability.

    Oakes ND, Thalén PG, Jacinto SM, Ljung B.

    Diabetes. 2001 May;50(5):1158-65.PMID: 11334421 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Pioglitazone induces in vivo adipocyte differentiation in the obese Zucker fa/fa rat.

    Hallakou S, Doaré L, Foufelle F, Kergoat M, Guerre-Millo M, Berthault MF, Dugail I, Morin J, Auwerx J, Ferré P.

    Diabetes. 1997 Sep;46(9):1393-9.PMID: 9287037 [PubMed - indexed for MEDLINE]Related articles

    12.

    Effect of rosiglitazone on insulin sensitivity and body composition in type 2 diabetic patients [corrected].

    Carey DG, Cowin GJ, Galloway GJ, Jones NP, Richards JC, Biswas N, Doddrell DM.

    Obes Res. 2002 Oct;10(10):1008-15. Erratum in: Obes Res. 2002 Nov;10(11):following table of contents.. PMID: 12376581 [PubMed - indexed for MEDLINE]Related articles

    13.

    Appearance of brown adipocytes in white adipose tissue during CL 316,243-induced reversal of obesity and diabetes in Zucker fa/fa rats.

    Ghorbani M, Himms-Hagen J.

    Int J Obes Relat Metab Disord. 1997 Jun;21(6):465-75.PMID: 9192230 [PubMed - indexed for MEDLINE]Related articles

    14.

    Depot-specific regulation of perilipin by rosiglitazone in a diabetic animal model.

    Kim HJ, Jung TW, Kang ES, Kim DJ, Ahn CW, Lee KW, Lee HC, Cha BS.

    Metabolism. 2007 May;56(5):676-85.PMID: 17445544 [PubMed - indexed for MEDLINE]Related articles

    15.

    Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients.

    Miyazaki Y, Mahankali A, Matsuda M, Mahankali S, Hardies J, Cusi K, Mandarino LJ, DeFronzo RA.

    J Clin Endocrinol Metab. 2002 Jun;87(6):2784-91.PMID: 12050251 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Dietary fat-induced increase in blood pressure and insulin resistance in rats.

    Yoshioka S, Uemura K, Tamaya N, Tamagawa T, Miura H, Iguchi A, Nakamura J, Hotta N.

    J Hypertens. 2000 Dec;18(12):1857-64.PMID: 11132611 [PubMed - indexed for MEDLINE]Related articles

    17.

    Repeat treatment of obese mice with BRL 49653, a new potent insulin sensitizer, enhances insulin action in white adipocytes. Association with increased insulin binding and cell-surface GLUT4 as measured by photoaffinity labeling.

    Young PW, Cawthorne MA, Coyle PJ, Holder JC, Holman GD, Kozka IJ, Kirkham DM, Lister CA, Smith SA.

    Diabetes. 1995 Sep;44(9):1087-92.PMID: 7657033 [PubMed - indexed for MEDLINE]Related articles

    18.

    Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance.

    Weyer C, Foley JE, Bogardus C, Tataranni PA, Pratley RE.

    Diabetologia. 2000 Dec;43(12):1498-506.PMID: 11151758 [PubMed - indexed for MEDLINE]Related articles

    19.

    A new antidiabetic agent, BRL 49653, reduces lipid availability and improves insulin action and glucoregulation in the rat.

    Oakes ND, Kennedy CJ, Jenkins AB, Laybutt DR, Chisholm DJ, Kraegen EW.

    Diabetes. 1994 Oct;43(10):1203-10.PMID: 7926289 [PubMed - indexed for MEDLINE]Related articles

    20.

    Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients.

    Bajaj M, Suraamornkul S, Piper P, Hardies LJ, Glass L, Cersosimo E, Pratipanawatr T, Miyazaki Y, DeFronzo RA.

    J Clin Endocrinol Metab. 2004 Jan;89(1):200-6.PMID: 14715850 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity